204 related articles for article (PubMed ID: 8182546)
1. Inotropic effect of the cardioprotective agent 2,3-butanedione monoxime in failing and nonfailing human myocardium.
Schwinger RH; Böhm M; Koch A; Morano I; Rüegg JC; Erdmann E
J Pharmacol Exp Ther; 1994 May; 269(2):778-86. PubMed ID: 8182546
[TBL] [Abstract][Full Text] [Related]
2. "Cardioplegia on the contractile apparatus level": evaluation of a new concept for myocardial preservation in perfused pig hearts.
Vahl CF; Bonz A; Hagl C; Timek T; Herold U; Fuchs H; Kochsiek N; Hagl S
Thorac Cardiovasc Surg; 1995 Aug; 43(4):185-93. PubMed ID: 7502280
[TBL] [Abstract][Full Text] [Related]
3. Cardiac inotropic as well as coronary and pulmonary artery actions of epinine in human isolated tissues.
Schwinger RH; Böhm M; Schulz C; Schmidt U; Schmidt U; Schmid B; Dienemann H; Reichart B; Erdmann E
J Pharmacol Exp Ther; 1993 Apr; 265(1):346-57. PubMed ID: 8386240
[TBL] [Abstract][Full Text] [Related]
4. Regional expression and functional characterization of the L-type Ca2+-channel in myocardium from patients with end-stage heart failure and in non-failing human hearts.
Schwinger RH; Hoischen S; Reuter H; Hullin R
J Mol Cell Cardiol; 1999 Jan; 31(1):283-96. PubMed ID: 10072735
[TBL] [Abstract][Full Text] [Related]
5. Increase of the extracellular magnesium concentration reduces cardiac glycoside toxicity in the human myocardium.
Schwinger RH; Böhm M; Uhlmann R; La Rosée K; Koch A; Erdmann E
J Pharmacol Exp Ther; 1992 Dec; 263(3):1352-9. PubMed ID: 1469639
[TBL] [Abstract][Full Text] [Related]
6. Different effect of the Ca(2+) sensitizers EMD 57033 and CGP 48506 on cross-bridge cycling in human myocardium.
Brixius K; Mehlhorn U; Bloch W; Schwinger RH
J Pharmacol Exp Ther; 2000 Dec; 295(3):1284-90. PubMed ID: 11082466
[TBL] [Abstract][Full Text] [Related]
7. Enantioselective inotropic actions of the Na+-channel activators BDF 9148, BDF 9196 and BDF 9167 in human failing and nonfailing myocardium.
Schwinger RH; Müller-Ehmsen J; Böhm M; Erdmann E
J Pharmacol Exp Ther; 1996 Mar; 276(3):1180-8. PubMed ID: 8786551
[TBL] [Abstract][Full Text] [Related]
8. Increase of atrial ANP release by 2,3-butanedione monoxime in beating rabbit atria.
Jin JY; Li D; Wen JF; Cho KW
Regul Pept; 2009 Nov; 158(1-3):91-6. PubMed ID: 19523992
[TBL] [Abstract][Full Text] [Related]
9. Inotropic and coronary vasodilatory actions of the K-adenosine triphosphate channel modulator nicorandil in human tissue.
Müller-Ehmsen J; Brixius K; Hoischen S; Schwinger RH
J Pharmacol Exp Ther; 1996 Dec; 279(3):1220-8. PubMed ID: 8968344
[TBL] [Abstract][Full Text] [Related]
10. Modulation of cross-bridge interaction by 2,3-butanedione monoxime in human ventricular myocardium.
Brixius K; Schwinger RH
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):440-4. PubMed ID: 10763860
[TBL] [Abstract][Full Text] [Related]
11. Intracellular Ca2+, force and activation heat in rabbit papillary muscle: effects of 2,3-butanedione monoxime.
Kotsanas G; Holroyd SM; Wendt IR; Gibbs CL
J Mol Cell Cardiol; 1993 Nov; 25(11):1349-58. PubMed ID: 8301668
[TBL] [Abstract][Full Text] [Related]
12. Force-frequency-relation in human atrial and ventricular myocardium.
Schwinger RH; Böhm M; Koch A; Uhlmann R; Uberfuhr P; Kreuzer E; Reichart B; Erdmann E
Mol Cell Biochem; 1993 Feb; 119(1-2):73-8. PubMed ID: 8455589
[TBL] [Abstract][Full Text] [Related]
13. Increase in force of contraction by activation of the Na+/Ca(2+)-exchanger in human myocardium.
Müller-Ehmsen J; Frank K; Brixius K; Schwinger RH
Br J Clin Pharmacol; 1997 Apr; 43(4):399-405. PubMed ID: 9146852
[TBL] [Abstract][Full Text] [Related]
14. Ca++ sensitizers impair cardiac relaxation in failing human myocardium.
Hajjar RJ; Schmidt U; Helm P; Gwathmey JK
J Pharmacol Exp Ther; 1997 Jan; 280(1):247-54. PubMed ID: 8996203
[TBL] [Abstract][Full Text] [Related]
15. Interpretation of the inotropic effect of 2,3-butanedione monoxime on the isometric twitch of guinea-pig papillary muscle.
Lammerich A; Holzhütter HG; Janiak R; Storch E; Günther J
Gen Physiol Biophys; 1994 Oct; 13(5):377-92. PubMed ID: 7797046
[TBL] [Abstract][Full Text] [Related]
16. Contractile deactivation and uncoupling of crossbridges. Effects of 2,3-butanedione monoxime on mammalian myocardium.
Gwathmey JK; Hajjar RJ; Solaro RJ
Circ Res; 1991 Nov; 69(5):1280-92. PubMed ID: 1934358
[TBL] [Abstract][Full Text] [Related]
17. Evidence for an interaction of halothane with the L-type Ca2+ channel in human myocardium.
Schmidt U; Schwinger RH; Böhm S; Uberfuhr P; Kreuzer E; Reichart B; Meyer L; Erdmann E; Böhm M
Anesthesiology; 1993 Aug; 79(2):332-9. PubMed ID: 7688198
[TBL] [Abstract][Full Text] [Related]
18. Effect of cyclopiazonic acid on the force-frequency relationship in human nonfailing myocardium.
Schwinger RH; Brixius K; Bavendiek U; Hoischen S; Müller-Ehmsen J; Bölck B; Erdmann E
J Pharmacol Exp Ther; 1997 Oct; 283(1):286-92. PubMed ID: 9336335
[TBL] [Abstract][Full Text] [Related]
19. Ouabain increases myofibrillar Ca2+ sensitivity but does not influence the Ca2+ release in human skinned fibres.
Hambarchian N; Brixius K; Lu R; Müller-Ehmsen J; Schwinger RH
Eur J Pharmacol; 2004 May; 492(2-3):225-31. PubMed ID: 15178369
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of the contractile effects of 2,3-butanedione-monoxime in the mammalian heart.
Zimmermann N; Boknik P; Gams E; Gsell S; Jones LR; Maas R; Neumann J; Scholz H
Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):431-6. PubMed ID: 8897445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
